China Biologic Products (01177): The latest research data on TQF6422 "ACTRII A/B monoclonal antibody" was released in ECO in 2026.

Zhifubao Financial News APP News, China Biopharmaceutical (01177) announced that the preclinical research data of the innovative drug TQF6422 "ActRII A/B monoclonal antibody" developed independently by its subsidiary Zhen Da Tian Qing Pharmaceutical Group Co., Ltd. ("Zhen Da Tian Qing") has been released at the 2026 European Congress on Obesity (ECO).